Literature DB >> 8361211

Analysis of Pim-1 function in mutant mice.

J Domen1, N M van der Lugt, P W Laird, C J Saris, A Berns.   

Abstract

The Pim-1 gene has frequently been found activated by proviral insertion in haematopoietic tumors in mice. The fact that overexpression of Pim-1 can contribute to lymphomagenesis was formally proven by overexpressing a Pim-1 transgene in lymphoid cells. The transgene induces a low incidence of T cell lymphomas and an increased susceptibility to chemically (ENU) and virally (MoMuLV) induced lymphomas. The mouse Pim-1 gene encodes two cytoplasmic protein-serine/threonine kinases. Northern analysis shows the highest expression to be in haematopoietic tissues, especially early in development. High expression has also been noted in testis and ES cells. Expression can be induced by growth factors and mitogens. The gene is evolutionarily highly conserved. Inactivation of both Pim-1 alleles in ES cells or mice did not reveal any obvious abnormalities. In order to look more closely for possible haematopoietic abnormalities specific growth factor response were studied in vitro. The IL-3 response of bone marrow-derived mast-cell cultures (BMMC) was found to be severely impaired in mast cells derived from Pim-1 deficient mice.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8361211

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  6 in total

Review 1.  Why target PIM1 for cancer diagnosis and treatment?

Authors:  Nancy S Magnuson; Zeping Wang; Gang Ding; Raymond Reeves
Journal:  Future Oncol       Date:  2010-09       Impact factor: 3.404

2.  Identification of quinones as novel PIM1 kinase inhibitors.

Authors:  Richard L Schroeder; Navneet Goyal; Melyssa Bratton; Ian Townley; Nancy A Pham; Phan Tram; Treasure Stone; Jasmine Geathers; Kathy Nguyen; Jayalakshmi Sridhar
Journal:  Bioorg Med Chem Lett       Date:  2016-04-28       Impact factor: 2.823

3.  c-Myb regulates the proliferation of immature thymocytes following beta-selection.

Authors:  R Pearson; K Weston
Journal:  EMBO J       Date:  2000-11-15       Impact factor: 11.598

4.  Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study.

Authors:  Eric D Hsi; Sin-Ho Jung; Raymond Lai; Jeffrey L Johnson; James R Cook; Dan Jones; Sven Devos; Bruce D Cheson; Lloyd E Damon; Jonathan Said
Journal:  Leuk Lymphoma       Date:  2008-11

5.  PIM1 reconstitutes thymus cellularity in interleukin 7- and common gamma chain-mutant mice and permits thymocyte maturation in Rag- but not CD3gamma-deficient mice.

Authors:  H Jacobs; P Krimpenfort; M Haks; J Allen; B Blom; C Démollière; A Kruisbeek; H Spits; A Berns
Journal:  J Exp Med       Date:  1999-10-18       Impact factor: 14.307

Review 6.  The Role of PIM Kinases in Pediatric Solid Tumors.

Authors:  Janet Rae Julson; Raoud Marayati; Elizabeth Ann Beierle; Laura Lee Stafman
Journal:  Cancers (Basel)       Date:  2022-07-22       Impact factor: 6.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.